CRT's overarching mission is to maximise cancer patient benefit through the development and commercialisation of discoveries arising from publicly funded research. In this regard, CRT provides an internationally recognized oncology-focused technology transfer and development service. Our success is founded on an in-depth understanding of oncology, supported through our strategic focus, and our multidisciplinary approach to technology transfer. Importantly, our activities are supported by in-house applied development capabilities and development funding, in addition to patenting, legal and business development resources. Scientists working with CRT can be assured they will receive the best possible service from professionals who understand oncology and its relevance within the commercial sector.

CRT offers cancer scientists unique technology transfer and development capabilities:

• Over 20 years' successful experience of choosing the optimal development pathway and commercialisation route for new discoveries and inventions;
• Ability to undertake rapid applied development to add value to new inventions through CRT's Development Laboratory and development funding;
• In-house professional patenting, legal and business development resources;
• In depth understanding of the needs of academic scientists, including publication processes and potential for ongoing involvement post-commercialisation;
• Access to reagents and tools to enhance research efforts;
• Strong credibility amongst a global network of oncology-focused biotechnology and pharmaceutical companies.

Scientists who wish to find out more about the services CRT can offer them should contact us.